China-Russia to Collaborate on Cancer Vaccine,Threatening Global Pharma Marke

China-Russia to Collaborate on Cancer Vaccine,Threatening Global Pharma Market

China is reportedly planning to approve Russia’s free-cancer vaccine and establish mutual pharmaceutical partnerships with Russian firms. 

The move is expected to significantly disrupt the US and European pharmaceutical markets, which are collectively valued at around $2.6 trillion.

Under the deal, Russia and China will jointly produce cancer vaccines and target sales to allied countries, potentially generating $1 trillion in revenue within two years